Oakley Capital Investments Limited

Declaration of Voting Results & Voting Rights Announcements • Jan 3, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0177M

Oakley Capital Investments Limited

03 January 2019

3 January 2019

Oakley Capital Investments Limited

Capital commitment to Oakley Capital IV

Oakley Capital Investments Limited1 (AIM: OCI), is pleased to announce it has made a commitment of €400 million to Oakley Capital IV, the successor fund to Oakley Capital Private Equity III2. Oakley Capital IV has materially the same strategy and commercial terms as Fund III.

- ends -

For further information please contact:

Oakley Capital Investments Limited

+44 20 7766 6900

Steven Tredget, Investor Relations

Greenbrook Communications Ltd

+44 20 7952 2000

Alex Jones / Matthew Goodman / Gina Bell

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Gillian Martin / Owen Matthews

1 About Oakley Capital Investments ("OCI")

OCI is an AIM listed investment vehicle, which provides access to the Oakley funds. It is a liquid vehicle that provides capital growth and dividends to investors.

LEI Number: 213800KW6MZUK12CQ815

2 The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II and Oakley Capital Private Equity III ("Fund III"), are unlisted focused mid-market private equity funds with the aim of providing investors with significant long-term capital appreciation. The investment strategy of the funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCFMGGMLZMGLZM